American Century Companies Inc. Decreases Stock Holdings in Health Catalyst, Inc. $HCAT

Key Points

• American Century Companies Inc. has significantly reduced its stake in Health Catalyst, Inc. by 83.4%, now holding only 0.17% of the company's shares after selling 592,507 shares in the first quarter.
• Health Catalyst's stock is currently trading at $3.38 per share, with analysts providing a consensus rating of "Hold" and a price target ranging from $4.00 to $5.00.
• Institutional ownership remains high, with approximately 85% of Health Catalyst's stock held by hedge funds and institutional investors, indicating strong market interest despite recent volatility.

American Century Companies Inc. decreased its holdings in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 83.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 117,974 shares of the company's stock after selling 592,507 shares during the quarter. American Century Companies Inc. owned about 0.17% of Health Catalyst worth $534,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of HCAT. Nepsis Inc. increased its position in Health Catalyst by 2,072.1% during the first quarter. Nepsis Inc. now owns 2,090,812 shares of the company's stock valued at $9,471,000 after acquiring an additional 1,994,555 shares during the last quarter. Nuveen LLC bought a new position in Health Catalyst during the first quarter valued at $2,674,000. Connor Clark & Lunn Investment Management Ltd. increased its position in Health Catalyst by 172.6% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 694,361 shares of the company's stock valued at $3,145,000 after acquiring an additional 439,599 shares during the last quarter. Palogic Value Management L.P. bought a new position in Health Catalyst during the fourth quarter valued at $2,262,000. Finally, AMH Equity Ltd bought a new position in Health Catalyst during the first quarter valued at $1,144,000. Institutional investors own 85.00% of the company's stock.

Health Catalyst Stock Down 0.6%

Health Catalyst stock traded down $0.02 during midday trading on Thursday, hitting $3.24. 566,293 shares of the company's stock were exchanged, compared to its average volume of 872,961. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.83 and a current ratio of 1.83. Health Catalyst, Inc. has a 12 month low of $2.52 and a 12 month high of $9.24. The firm has a 50-day moving average of $3.53 and a two-hundred day moving average of $3.88. The company has a market cap of $228.00 million, a PE ratio of -2.15 and a beta of 1.53.

Analyst Ratings Changes

A number of research analysts have recently commented on HCAT shares. Wells Fargo & Company cut their price target on shares of Health Catalyst from $10.00 to $6.00 and set an "overweight" rating on the stock in a report on Monday, August 11th. Cantor Fitzgerald restated a "neutral" rating and issued a $4.00 price target (down from $9.00) on shares of Health Catalyst in a report on Friday, August 8th. Stifel Nicolaus cut their price target on shares of Health Catalyst from $5.50 to $4.50 and set a "hold" rating on the stock in a report on Friday, August 8th. Evercore ISI upped their price target on shares of Health Catalyst from $3.00 to $4.00 and gave the stock an "in-line" rating in a report on Thursday, August 28th. Finally, Summit Redstone set a $5.00 price target on shares of Health Catalyst in a report on Friday, August 29th. Three equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $4.73.

Health Catalyst Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.